De novo programmed cell death in oral cancer

被引:37
作者
Ravi, D
Ramadas, K
Mathew, BS
Nalinakumari, KR
Nair, MK
Pillai, MR [1 ]
机构
[1] Reg Canc Ctr, Div Lab Med, Thiruvananthapuram 695011, Kerala, India
[2] Reg Canc Ctr, Div Radiat Oncol, Thiruvananthapuram 695011, Kerala, India
[3] Reg Canc Ctr, Div Dent Surg, Thiruvananthapuram 695011, Kerala, India
关键词
apoptosis; p53; bcl-2; bax; proliferation;
D O I
10.1046/j.1365-2559.1999.00575.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aim: The importance of programmed cell death or apoptosis in the maintenance of tissue homoeostasis and the pathogenesis of oral cancer was analysed in relation to apoptosis regulatory proteins, tissue proliferation and tumour histology. Methods and results: The extent of apoptosis was defined by morphological criteria and the TUNEL (terminal deoxy nucleotidyl transferase-mediated dUTP biotin nick end labelling) assay p53, bax, bcl-2 and cyclin D1 expression was evaluated by immunocytochemistry. The presence of mutant p53 was analysed using a mutant p53-specific ELISA. An inverse correlation was observed between TUNEL reactivity and histology of the lesion (r = -0.555, P = 0.0001), There was also correlation between TUNEL reactivity and immunoreactivity of apoptosis regulatory proteins, p53 (r = 0.641. P = 0.00023), bcl-2 (r = -0.642, P = 0.00014) and bax (r = 0.651, P = 0.00002). The presence of mutant p53 protein showed an inverse correlation to the extent of apoptosis (r = -0.301, P = 0.00063). significant correlation was evident between the bax/bcl-2 ratio and TUNEL (r = 0.652, P = 0.00001) as well as between cyclin D1 and TUNEL reactivity (r = 0.577, P = 0.00001). Conclusions: results from this study suggest that apoptosis decreases as histological abnormality increases. Apoptotic regulatory proteins are also altered in a histologically dependent manner. Deregulated proliferation occurs simultaneously with decreased apoptosis during tumour progression in the oral mucosa.
引用
收藏
页码:241 / 249
页数:9
相关论文
共 29 条
  • [1] FREQUENCY OF APOPTOTIC BODIES POSITIVELY CORRELATES WITH GLEASON GRADE IN PROSTATE-CANCER
    AIHARA, M
    TRUONG, LD
    DUNN, JK
    WHEELER, TM
    SCARDINO, PT
    THOMPSON, TC
    [J]. HUMAN PATHOLOGY, 1994, 25 (08) : 797 - 801
  • [2] AIHARA M, 1995, CANCER-AM CANCER SOC, V75, P522, DOI 10.1002/1097-0142(19950115)75:2<522::AID-CNCR2820750215>3.0.CO
  • [3] 2-W
  • [4] BEDI A, 1995, CANCER RES, V55, P1811
  • [5] Bockmuhl U, 1998, HEAD NECK-J SCI SPEC, V20, P145, DOI 10.1002/(SICI)1097-0347(199803)20:2<145::AID-HED8>3.0.CO
  • [6] 2-2
  • [7] Clayman GL, 1996, CANCER MED-US, V4th, P1645
  • [8] Apoptosis: Its role in the development of malignancies and its potential as a novel therapeutic target
    Dixon, SC
    Soriano, BJ
    Lush, RM
    Borner, MM
    Figg, WD
    [J]. ANNALS OF PHARMACOTHERAPY, 1997, 31 (01) : 76 - 82
  • [9] IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION
    GAVRIELI, Y
    SHERMAN, Y
    BENSASSON, SA
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 119 (03) : 493 - 501
  • [10] HENZEL PA, 1996, INT J CANCER, V68, P1